Abstract
Transcatheter mitral valve implantation (TMVI) is a novel treatment alternative for patients with symptomatic mitral regurgitation (MR). We conducted a retrospective analysis of the efficacy and safety of TMVI using the Tendyne device vs transcatheter edge-to-edge repair (TEER) using the MitraClip.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
